Ongoing clinical trials and approved products targeting Norepinephrine transporter, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.
| MIBG [123I] (AdreView…)[123I]iobenguane | GE HealthCare, Curium | marketed | US EU FR JP |
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| MIBG and analogues (innervation, neural crest)NCT06120049 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | prof. dr. Koen Van Laere | 1 |
| IRP101-231 · MIBG and analogues (innervation, neural crest)NCT07176286 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 1 |
| MIBG and analogues (innervation, neural crest)2022-501694-39-01 · Neuroblastoma | Phase 2 | Recruiting | Princess Maxima Center For Pediatric Oncology | 1 |
| MIBG and analogues (innervation, neural crest)NCT05514106 · Alzheimer's disease and cognitive disorders | No phase | By invitation | Mayo Clinic | 1 |
| MIBG and analogues (innervation, neural crest)NCT05826158 · Neuroblastoma | No phase | Recruiting | Copenhagen University Hospital, Rigshospitalet | 1 |
Norepinephrine transporter. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/norepinephrine-transporter/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.